| Financial Year |
March 31 2023 |
| Monetary Funds |
84,312,518.46 |
| Held-for-trading Financial Assets |
399,757,895.77 |
| Notes Receivable |
3,523,347.74 |
| Accounts Receivable |
132,340,109.61 |
| Advances to Suppliers |
6,254,000.07 |
| Other Receivables |
6,996,949.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
130,285,616.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,905,365.26 |
| Total Current Assets |
773,375,803.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
281,700.26 |
| Investment Properties |
-- |
| Fixed Assetes |
121,752,865.90 |
| Under-construction Projects |
80,647,249.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,832,586.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,385,044.34 |
| Deferred Income Tax Assets |
8,278,797.23 |
| Other Non-Current Assets |
1,336,373.07 |
| Sub-Total of Non-Current Assets |
1,155,882,683.94 |
| Total Assets |
1,929,258,487.39 |
| Short-Term Loans |
4,370,216.98 |
| Trading Financial liabilities |
292,053.70 |
| Notes Payable |
66,358,728.79 |
| Accounts Payable |
145,783,450.20 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
19,419,230.32 |
| Taxes Payable |
20,518,131.24 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
50,512,693.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,511,510.44 |
| Other Current Liabilities |
4,703,538.75 |
| Sub-Total of Current Liabilities |
322,619,206.79 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
3,027,604.25 |
| Deferred Income Tax Liabilities |
31,916,142.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
36,453,883.82 |
| Total Liabilities |
359,073,090.61 |
| Paid-In Capital(Or Share Stock) |
577,504,854.00 |
| Capital Surplus |
903,782,958.54 |
| Surplus Reserve |
55,319,740.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-45,010,455.14 |
| Minority Stockholder's Interest |
51,607,506.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,518,577,890.16 |
| Owner's Equity（Stockholder's Equity） |
1,570,185,396.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,929,258,487.39 |
